J Rhinol.  2017 Nov;24(2):104-111. 10.18787/jr.2017.24.2.104.

Comparison of Manuka, Kanuka, and Black Locust Honey on the Production of Chemical Mediators by Peripheral Blood Mononuclear Cells

Affiliations
  • 1Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Catholic University of Daegu, Daegu, Korea. hsseung@cu.ac.kr

Abstract

BACKGROUND AND OBJECTIVES
Honey has various biological and pharmacological activities and has been used as treatment against various inflammatory diseases. The aim of this study was to compare the anti-inflammatory characteristics of manuka, kanuka, and black locust honey. MATERIALS AND METHOD: Peripheral blood mononuclear cells (PBMCs) from healthy human volunteers were isolated and then stimulated with lipopolysaccharide (LPS) with or without pre-treatment of various concentrations of honey for 72 hours. The cytotoxic effects of honeys were measured using an aqueous cell proliferation kit, and the supernatants were analyzed for interleukin-5 (IL-5), IL-10, interferon-γ (INF-γ), and tumor necrosis factor-α (TNF-α) using an enzyme-linked immunosorbent assay.
RESULTS
Samples of 1% manuka and kanuka honey were found to have cytotoxic effects on PBMCs. Honey itself enhanced the production of IL-10 and TNF-α production. Manuka and kanuka honeys suppressed LPS-induced IL-10 and INF-γ production, while black locust honey only suppressed IL-10 production from PBMCs.
CONCLUSION
Honeys had immunomodulatory properties of both immunostimulatory and immunosuppressive effects on PBMCs. Different honeys might have different immune modulatory functions due to their different components.

Keyword

Manuka honey; Kanuka honey; Black locust honey; Peripheral blood mononuclear cell; Anti-inflammation

MeSH Terms

Cell Proliferation
Enzyme-Linked Immunosorbent Assay
Healthy Volunteers
Honey*
Interleukin-10
Interleukin-5
Kunzea*
Methods
Necrosis
Robinia*
Interleukin-10
Interleukin-5

Figure

  • Fig. 1 Cytotoxic effect of honeys on peripheral blood mononuclear cells (PBMCs) at various concentrations of manuka, kanuka, and black locust honey. PBMCs from five healthy individuals were treated with honeys for 72 hours. 1% of manuka (A) and kanuka (B) honeys significantly suppressed the proliferation PBMCs. However, under the 1% concentration, of black locust honey (C) did not influence the proliferation of PBMCs. NT: non-treated, M: manuka honey, K: kanuka honey, B: black locust honey, *: p<0.05 vs negative control.

  • Fig. 2 Cytotoxic effect of honeys on peripheral blood mononuclear cells (PBMCs) at various concentrations of manuka, kanuka, and black locust honey with 10 ug/ml of lipopolysaccharide (LPS). PBMCs were pretreated with honeys for 1 hour and then cultured with LPS for 48 hours. 1% of manuka, kanuka, and black locust honeys significantly suppressed the proliferation of PBMCs. NT: non-treated, M: manuka honey, K: kanuka honey, B: black locust honey, *: p<0.05 vs negative control.

  • Fig. 3 Influence of manuka, kanuka, and black locust honey on cytokine production by peripheral blood mononuclear cells (PBMCs). PBMCs were cultured with various concentrations of honeys. Manuka (A) and kanuka (B) honey enhanced TNF-α and IL-10 production and black locust honey (C) enhanced only TNF-α production from PBMCs. NT: non-treated, M: manuka honey, K: kanuka honey, B: black locust honey. *: p<0.05 vs negative control.

  • Fig. 4 Influence of honeys on cytokine production by peripheral blood mononuclear cells (PBMCs). PBMCs were stimulated with lipopolysaccharide (LPS) for 72 hours with or without pre-treatment with various concentrations of manuka (A), kanuka (B), and black locust (C) honey. LPS induced INF-γ and IL-10 productions were significantly inhibited with 0.5% of honeys. M: manuka honey, K: kanuka honey, B: black locust honey. *: p<0.05 vs LPS group.


Reference

1. Zumla A, Lulat A. Honey - a remedy rediscovered. J R Soc Med. 1989; 82:384–385.
Article
2. Alandejani T, Marsan J, Ferris W, Slinger R, Chan F. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Head Neck Surg. 2009; 141:114–118.
Article
3. Leong AG, Herst PM, Harper JL. Indigenous New Zealand honeys exhibit multiple anti-inflammatory activities. Innate Immun. 2012; 18:459–466.
Article
4. Gannabathula S, Skinner MA, Rosendale D, Greenwood JM, Mutukumira AN, Stinhorn G, et al. Arabinogalactan proteins contributes to the immunostimulatory properties of New Zealand honeys. Immunopharmacol Immunotoxicol. 2012; 34:598–607.
Article
5. Weston RJ, Mitchell KR, Allen KL. Antibacterial phenolic components of New Zealand manuka honey. Food Chem. 1999; 64:295–301.
Article
6. Prakash A, Medhi B, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Phytother Res. 2008; 22:1511–1519.
Article
7. Nasuti C, Gabbianelli R, Falcioni G, Cantalamessa F. Antioxidative and gastroprotective activities of anti-inflammatory formulations derived from chestnut honey in rats. Nutr Res. 2006; 26:130–137.
Article
8. Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer. 2003; 11:242–248.
Article
9. Cha YH, Bang KS. Studies on the antibacterial activity of honey I. antibacterial activity of balack locust honey. Korean J Apiculture. 1999; 14:85–96.
10. Mesaik MA, Azim MK, Mohiuddin S. Honey modulates oxidative burst of professional phagocytes. Phytother Res. 2008; 22:1404–1408.
Article
11. Migdal W, Owczarczyk HB, Kedzia B, Holderna-Kedzia E, Madajczyk D. Microbiological decontamination of natural honey by irradiation. Radiat Phys Chem. 2007; 57:285–288.
Article
12. Molan PC, Allen KL. The effect of gamma-irradiation on the antibacterial activity of honey. J Pharm Pharmacol. 1996; 48:1206–1209.
Article
13. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002; 3:1129–1134.
Article
14. Tonks AJ, Dudley E, Porter NG, Parton J, Brazier J, Smith EL, et al. A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol. 2007; 82:1147–1155.
Article
15. Erejuwa OO, Sulaiman SA, Wahab MS. Effects of honey and its mechanisms of action on the development and progression of cancer. Molecules. 2014; 19:2497–2522.
Article
16. van den Berg AJ, van den Worm E, van Ufford HCQ, Halkes SBA, Hoekstra MJ, Beukelman CJ. An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey. J Wound Care. 2008; 17:172–178. 176–178.
Article
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr